At present, a bone marrow transplant is the only cure available for some people living with sickle cell disease. However, it is an intensive treatment that carries a number of risks. Sickle cell ...
A bone marrow transplant process co-developed by investigators at the Johns Hopkins Kimmel Cancer Center is safe and curative for adults with sickle cell disease, according to results of a trial ...
A reduced-intensity bone marrow transplant regimen developed by Johns Hopkins physicians provides durable engraftment with low rejection rates and also may preserve fertility, according to results of ...
On her best days, Tatyana Thompson’s pain was at a level five. Some days, it would stay that way, a persistent throb in her joints, her hands, her back. On other days, if she was dehydrated or was hit ...
Today is World Sickle Cell Disease Day. The international awareness day is observed annually to increase public knowledge and an understanding of sickle cell disease and the challenges experienced by ...
In an estimated 2–3% of the population, the condition causes chronic pain, repeated hospital admissions, organ damage, and dramatically reduced life expectancy. Now, Nigeria has opened West Africa’s ...
It was only 11 years ago that scientists Jennifer Doudna and Emmanuelle Charpentier first described a new way to edit genes, called CRISPR, in a scientific paper. The discovery is so game-changing ...
Saritee Sanodiya, 26, has spent countless days wondering if she’ll ever live a “normal” life. Growing up, Sanodiya often missed school, frequenting the hospital for sudden, life-threatening drops in ...
A reduced-intensity bone marrow transplant regimen developed by Johns Hopkins physicians provides durable engraftment with low rejection rates and also may preserve fertility, according to results of ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results